CHAPTER 1. INTRODUCTION
1.1. Market Definition
1.2. Executive Summary
1.3. The Scope of the Study
CHAPTER 2. RESEARCH METHODOLOGY
2.1. Secondary Research
2.2. Primary Research
2.3. Analytic Tools and Model
2.4. Economic Indicator
2.4.1 Base Year, Base Currency, Forecasting Period
2.5. Expert Validation
2.6. Study Timeline
CHAPTER 3. MARKET ANALYSIS
3.1. Industry Value Chain Analysis
3.2. Porter's Five Force Analysis
3.2.1. Bargaining Power of Buyers
3.2.2. Bargaining Power of Suppliers
3.2.3. Threats of Substitutes
3.2.4. Threats of New Entrants
3.2.5. Degree of Competition
3.3. PESTLE Analysis
3.3.1. Political
3.3.2. Economical
3.3.3. Social
3.3.4. Technological
3.3.5. Legal
3.3.6. Environmental
3.4. SWOT Analysis
3.4.1. Strengths
3.4.2. Weakness
3.4.3. Opportunities
3.4.4. Threats
3.5. Y-O-Y Analysis
CHAPTER 4. MARKET DYNAMICS
4.1. Market Drivers
4.1.1. Advancements in clinical diagnostic techniques
4.1.2. Rising demand for early and accurate disease diagnosis and increasing burden of target
diseases
4.1.3. Growing public-private investments as well as research funding & grants to develop
innovative laboratory testing procedures
4.2. Market Restraints & Challenges
4.2.1. Public concerns related to data security and privacy
4.2.2. The procedural shift from lab-based diagnosis to home-based/point-of-care testing
procedures
4.2.3. Pricing pressure faced by healthcare payers and providers
4.3. Market Opportunities
4.3.1. Growing adoption of digital pathology platforms
4.3.2. Patient-initiated diagnostic testing to foster market growth in developed economies
4.3.3. Rising preference for comprehensive health checkups offered by clinical laboratories
CHAPTER 5. GLOBAL CLINICAL LABORATORY SERVICES MARKET – BY
SPECIALTY
5.1. Immunology Testing
5.2. Cytology Testing
5.3. Genetic Testing
5.4. Drugs of Abuse Testing
5.5. Microbiology Testing
5.5.1. Transplant Diagnostic Testing
5.5.2. Infectious Disease Testing
5.5.3. Others
5.6. Clinical Chemistry Testing
5.6.1. Therapeutic Drug Monitoring Testing
5.6.2. Routine Chemistry Testing
5.6.3. Endocrinology Chemistry Testing
5.6.4. Specialized Chemistry Testing
5.6.5. Others
5.7. Haematology Testing
5.7.1. Coagulation Testing
5.7.2. Specialized Hematology Testing
5.7.3. Routine Hematology Testing
CHAPTER 6. GLOBAL CLINICAL LABORATORY SERVICES MARKET – BY
PROVIDER
6.1. Nursing and Physician Office-Based Laboratories
6.2. Independent & Reference Laboratories
6.3. Hospital-Based Laboratories
6.4. Others
CHAPTER 7. GLOBAL CLINICAL LABORATORY SERVICES MARKET – BY
GEOGRAPHY
7.1. Introduction
7.2. North America
7.2.1. U.S.
7.2.2. Canada
7.2.3. Mexico
7.2.4. Costa Rica
7.3. South America
7.3.1. Brazil
7.3.2. Argentina
7.3.3. Chile
7.3.4. Columbia
7.3.5. Others
7.4. Europe
7.4.1. U.K.
7.4.2. Germany
7.4.3. France
7.4.4. Italy
7.4.5. Spain
7.4.6. Russia
7.4.7. Netherlands
7.4.8. Switzerland
7.4.9. Poland
7.4.10. Others
7.5. APAC
7.5.1. China
7.5.2. Japan
7.5.3. India
7.5.4. South Korea
7.5.5. Australia & New Zealand
7.5.6. Malaysia
7.5.7. Singapore
7.5.8. Others
7.6. Middle East & Africa
7.6.1. UAE
7.6.2. Saudi Arabia
7.6.3. Iran
7.6.4. Iraq
7.6.5. Qatar
7.6.6. South Africa
7.6.7. Algeria
7.6.8. Morocco
7.6.9. Nigeria
7.6.10. Egypt
7.6.11. Others
CHAPTER 8. GLOBAL CLINICAL LABORATORY SERVICES MARKET -
COMPANY PROFILES
8.1. Spectra Laboratories, Inc.
8.2. Charles River Laboratories, Inc.
8.3. Arup Laboratories, Inc.
8.4. Abbott Laboratories, Inc.
8.5. Fullerton Health Group
8.6. Bioreference Laboratories, Inc.
8.7. Qiagen N.V.
8.8. Quest Diagnostics Inc.
8.9. Laboratory Corporation of America Holdings
8.10. Clarient, Inc.
8.11. Genoptix Medical Laboratory
8.12. Labco S.A.
8.13. Sonic Healthcare Ltd.
8.14. Siemens PLM
CHAPTER 9. GLOBAL CLINICAL LABORATORY SERVICES MARKET –
COMPETITIVE LANDSCAPE
9.1. Market Share Analysis
9.2. Strategies adopted by top companies
9.3. Mergers, Acquisitions, Collaborations & Agreements
CHAPTER 10. MARKET INSIGHTS
10.1. Industry Experts Insights
10.2. Analysts Opinions
10.3. Investment Opportunities
CHAPTER 11. APPENDIX
11.1. List of Tables
11.2. List of Figures
